Comparison of intravascular ultrasound-guided with angiography-guided double kissing crush stenting for patients with complex coronary bifurcation lesions: Rationale and design of a prospective, randomized, and multicenter DKCRUSH VIII trial

Double kissing (DK) crush approach for patients with coronary bifurcation lesions, particularly localized at distal left main or lesions with increased complexity, is associated with significant reduction in clinical events when compared with provisional stenting. Recently, randomized clinical trial...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American heart journal 2021-04, Vol.234, p.101-110
Hauptverfasser: Ge, Zhen, Kan, Jing, Gao, Xiao-Fei, Kong, Xiang-Quan, Zuo, Guang-Feng, Ye, Fei, Tian, Nai-Liang, Lin, Song, Liu, Zhi-Zhong, Sun, Zhi-Qi, He, Peng-Cheng, Wei, Lin, Yang, Wei, He, Yu-Quan, Xue, Yu-Zeng, Wang, Lian-Min, Miao, Li-Fu, Pu, Jun, Sun, Ya-Wu, Nie, Shao-Ping, Tao, Jian-Hong, Wen, Shang-Yu, Yang, Qing, Su, Xi, Yao, Qi-Cheng, Huang, Yi-Jie, Xia, Yong, Shen, Fa-Rong, Qiu, Chun-Guang, Mao, You-Lin, Liu, Qiang, Hu, Xin-Qun, Du, Zhi-Min, Nie, Ru-Qiong, Han, Ya-Ling, Zhang, Jun-Jie, Chen, Shao-Liang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Double kissing (DK) crush approach for patients with coronary bifurcation lesions, particularly localized at distal left main or lesions with increased complexity, is associated with significant reduction in clinical events when compared with provisional stenting. Recently, randomized clinical trial has demonstrated the net clinical benefits by intravascular ultrasound (IVUS)-guided implantation of drug-eluting stent in all-comers. However, the improvement in clinical outcome after DK crush treatment guided by IVUS over angiography guidance for patients with complex bifurcation lesions have never been studied in a randomized fashion. DKCRUSH VIII study is a prospective, multicenter, randomized controlled trial designed to assess superiority of IVUS-guided vs angiography-guided DK crush stenting in patients with complex bifurcation lesions according to DEFINITION criteria. A total of 556 patients with complex bifurcation lesions will be randomly (1:1 of ratio) assigned to IVUS-guided or angiography-guided DK crush stenting group. The primary end point is the rate of 12-month target vessel failure, including cardiac death, target vessel myocardial infarction, or clinically driven target vessel revascularization. The secondary end points consist of the individual component of primary end point, all-cause death, myocardial infarction, and in-stent restenosis. The safety end point is the incidence of definite or probable stent thrombosis. An angiographic follow-up will be performed for all patients at 13 months and clinical follow-up will be continued annually until 3 years after the index procedure. DKCRUSH VIII trial is the first study designed to evaluate the differences in efficacy and safety between IVUS-guided and angiography-guided DK crush stenting in patients with complex true bifurcation lesions. This study will also provide IVUS-derived criteria to define optimal DK crush stenting for bifurcation lesions at higher complexity.
ISSN:0002-8703
1097-6744
DOI:10.1016/j.ahj.2021.01.011